Evidence
- vanderzouwen_2023_cohort_feasibility-safety-efficacy-early-prophylactic-dli-tcd-allosct-acute-leukemia
- vanderzouwen_2023_cohort_feasibility-safety-efficacy-early-prophylactic-dli-tcd-allosct-acute-leukemia
- vanderzouwen_2023_cohort_feasibility-safety-efficacy-early-prophylactic-dli-tcd-allosct-acute-leukemia
- vanderzouwen_2023_cohort_feasibility-safety-efficacy-early-prophylactic-dli-tcd-allosct-acute-leukemia
- vanderzouwen_2023_cohort_feasibility-safety-efficacy-early-prophylactic-dli-tcd-allosct-acute-leukemia
Protocols
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-matched-sibling-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-ric-matched-sibling-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-ric-unrelated-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-unrelated-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-donor-lymphocyte-infusion-high-risk-acute-leukemia